These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1886717

  • 1. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
    Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A.
    Oncogene; 1991 Aug; 6(8):1465-70. PubMed ID: 1886717
    [Abstract] [Full Text] [Related]

  • 2. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.
    Manning AM, Williams AC, Game SM, Paraskeva C.
    Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA, Greenberg AH, Wright JA.
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [Abstract] [Full Text] [Related]

  • 4. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
    Longstreet M, Miller B, Howe PH.
    Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
    [Abstract] [Full Text] [Related]

  • 5. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
    Blaydes JP, Schlumberger M, Wynford-Thomas D, Wyllie FS.
    Oncogene; 1995 Jan 19; 10(2):307-17. PubMed ID: 7838530
    [Abstract] [Full Text] [Related]

  • 6. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA, Wright JA.
    J Cell Biochem; 1995 Mar 19; 57(3):543-56. PubMed ID: 7768988
    [Abstract] [Full Text] [Related]

  • 7. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
    Jhappan C, Takayama H, Dickson RB, Merlino G.
    Cell Growth Differ; 1994 Apr 19; 5(4):385-94. PubMed ID: 8043512
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
    Lo J, Hurta RA.
    Biochem Cell Biol; 2000 Dec 01; 78(4):527-35. PubMed ID: 11012093
    [Abstract] [Full Text] [Related]

  • 10. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
    Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C.
    Oncogene; 1994 May 01; 9(5):1479-85. PubMed ID: 8152811
    [Abstract] [Full Text] [Related]

  • 11. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
    Zhao J, Buick RN.
    Cancer Res; 1995 Dec 15; 55(24):6181-8. PubMed ID: 8521411
    [Abstract] [Full Text] [Related]

  • 12. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G.
    J Cell Physiol; 1997 Aug 15; 172(2):200-8. PubMed ID: 9258341
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
    Braun L, Gruppuso P, Mikumo R, Fausto N.
    Cell Growth Differ; 1990 Mar 15; 1(3):103-11. PubMed ID: 1964076
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells.
    Kim ES, Kim MS, Moon A.
    Cytokine; 2005 Jan 21; 29(2):84-91. PubMed ID: 15598443
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
    Casanova ML, Larcher F, Casanova B, Murillas R, Fernández-Aceñero MJ, Villanueva C, Martínez-Palacio J, Ullrich A, Conti CJ, Jorcano JL.
    Cancer Res; 2002 Jun 15; 62(12):3402-7. PubMed ID: 12067982
    [Abstract] [Full Text] [Related]

  • 19. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis.
    Gold LI, Jussila T, Fusenig NE, Stenbäck F.
    J Pathol; 2000 Apr 15; 190(5):579-88. PubMed ID: 10727984
    [Abstract] [Full Text] [Related]

  • 20. Genetic events and the role of TGF beta in epithelial tumour progression.
    Akhurst RJ, Balmain A.
    J Pathol; 1999 Jan 15; 187(1):82-90. PubMed ID: 10341708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.